Nach dem starken Rücksetzer der letzten 2 Monate, könnte es nach
der heutigen Meldung in nächster Zeit wieder nach oben gehen:
Bin aber momentan noch am überlegen
Vielleicht gibt es Meinungen dazu ?
Meldung von heute:
UPDATE 1-Synta gets FDA nod to resume developing cancer drug
* To resume development of skin cancer drug
* Expects to initiate one or more trials in H2 2010
March 2 (Reuters) - Synta Pharmaceuticals Corp (SNTA.O) said it
received approval from the U.S. health regulator to resume
developing its experimental skin cancer drug that was suspended
last year due to safety concerns.
Synta expects to initiate one or more clinical trials for the drug,
elesclomol, which is being developed for the treatment of
metastatic melanoma or the most deadly form of skin cancer, in the
second half of 2010.
Resuming development will allow the company to evaluate the
potential of the drug and analyze the recent data, Synta said.
A late-stage trial of the drug was suspended in February 2009 after
an independent data monitoring committee identified safety
concerns, including a greater number of deaths in patients taking
Following the trial suspension last year, Synta had cut nearly 40
percent of its workforce and saw its partner on the drug,
GlaxoSmithKline (GSK.L), walk away from a deal reverting all rights
to the drug to Synta.
Shares of the company closed at $4.02 Monday on Nasdaq.